ORKA
The table below shows Oruka Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $49.52M | $91.25M | $65.40M | $83.57M | $410.88M | $33.28M |
| Short-term investments | $339.31M | $257.90M | $263.01M | $265.52M | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $395.25M |
| $355.16M |
| $332.01M |
| $352.08M |
| $412.95M |
| $33.82M |
| Property, plant & equipment | $318.00K | $253.00K | $174.00K | $159.00K | $160.00K | $4.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $504.48M | $509.25M | $357.42M | $377.11M | $414.09M | $33.84M |
| Accounts payable | - | - | - | - | - | $571.00K |
| Total current liabilities | $16.63M | $20.97M | $12.11M | $11.72M | $18.04M | $1.27M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $17.76M | $22.46M | $13.78M | $12.39M | $18.88M | $1.27M |
| Retained earnings | -$220.98M | -$159.57M | -$129.30M | -$104.72M | -$57.94M | -$193.43M |
| Total equity | $486.72M | $486.79M | $343.64M | $364.73M | $342.37M | $32.57M |